|
rs2111902
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The aim of this study was therefore to examine the impact of G72 rs746187 and DAAO rs2111902 genotypes on brain function in schizophrenia, bipolar disorder and healthy volunteers.
|
22239582 |
2012 |
|
rs2111902
|
|
|
0.040 |
GeneticVariation |
BEFREE |
For each gene, we genotyped 213 cases and 197 controls for SNPs previously associated with schizophrenia: rs2111902 (MDAAO-4), rs3918346 (MDAAO-5), rs3741775 (MDAAO-6) and rs3918347 (MDAAO-7) in DAO and rs746187 (M7), rs3916966 (M13), rs2391191 (M15) and rs3916972 (M25) in G72.
|
18165970 |
2008 |
|
rs2111902
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The data suggest that evidence for association at DAO (marker rs2111902) is more consistent than previously realized, particularly in Caucasian schizophrenia populations.
|
17492767 |
2007 |
|
rs2111902
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In order to evaluate the potential association of these two genes with schizophrenia in a Taiwanese sample, three single nucleotide polymorphisms (SNPs) for DAAO (rs2111902, rs3918346, rs3741775) and eleven SNPs for G72 (rs3916965, rs3916966, rs3916967, rs2391191, rs3916968, rs947267, rs778294, rs3916970, rs3916971, rs778293, rs3918342) were genotyped by the MALDI-TOF mass spectrometry method in 218 families (864 individuals) containing at least two siblings affected with schizophrenia.
|
16842973 |
2006 |
|
rs3918347
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The schizophrenia risk G-allele of <i>DAO</i> rs3918347 nominally increased risk for those UHR individuals with attenuated positive symptoms syndrome.
|
29326614 |
2017 |
|
rs3918347
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The genetic case-control analysis showed that no individual single-nucleotide polymorphism (SNP) in any of the four genes was associated with schizophrenia; only the two (rs3918347-rs4964770, P=0.0009) and three (rs3825251-rs3918347-rs4964770, P=0.002) SNP-based haplotype analysis of the DAO gene showed an association with schizophrenia even after correction for multiple testing.
|
19223009 |
2009 |
|
rs3918347
|
|
|
0.030 |
GeneticVariation |
BEFREE |
For each gene, we genotyped 213 cases and 197 controls for SNPs previously associated with schizophrenia: rs2111902 (MDAAO-4), rs3918346 (MDAAO-5), rs3741775 (MDAAO-6) and rs3918347 (MDAAO-7) in DAO and rs746187 (M7), rs3916966 (M13), rs2391191 (M15) and rs3916972 (M25) in G72.
|
18165970 |
2008 |
|
rs4623951
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The updated meta-analyses resulted in the following findings: the C-allele of DAO rs4623951 was associated with schizophrenia across all pooled studies [Odds ratio (OR) = 0.88, 95% confidence interval (CI) = 0.79-0.98, p = 0.02, N = 3143]; however, no new reports could be included.
|
28864885 |
2018 |
|
rs3825251
|
|
|
0.020 |
GeneticVariation |
BEFREE |
This study aimed to determine the relationship of five single-nucleotide polymorphisms (SNPs) within the DAO gene identified as promising schizophrenia risk genes (rs4623951, rs2111902, rs3918346, rs3741775, and rs3825251) to acoustic startle, prepulse inhibition (PPI), working memory, and personality dimensions.
|
21471957 |
2011 |
|
rs3918346
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We examined the impact of DAAO genotype (rs3918346) on brain function in patients with schizophrenia, patients with bipolar I disorder and healthy controls.
|
21421061 |
2011 |
|
rs4623951
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The rs4623951_T allele, which is the DAO polymorphism most strongly associated with schizophrenia, might tag a haplotype that affects PPI, cognition, and personality traits in general population.
|
21471957 |
2011 |
|
rs3825251
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The genetic case-control analysis showed that no individual single-nucleotide polymorphism (SNP) in any of the four genes was associated with schizophrenia; only the two (rs3918347-rs4964770, P=0.0009) and three (rs3825251-rs3918347-rs4964770, P=0.002) SNP-based haplotype analysis of the DAO gene showed an association with schizophrenia even after correction for multiple testing.
|
19223009 |
2009 |
|
rs3741775
|
|
|
0.020 |
GeneticVariation |
BEFREE |
For each gene, we genotyped 213 cases and 197 controls for SNPs previously associated with schizophrenia: rs2111902 (MDAAO-4), rs3918346 (MDAAO-5), rs3741775 (MDAAO-6) and rs3918347 (MDAAO-7) in DAO and rs746187 (M7), rs3916966 (M13), rs2391191 (M15) and rs3916972 (M25) in G72.
|
18165970 |
2008 |
|
rs3918346
|
|
|
0.020 |
GeneticVariation |
BEFREE |
For each gene, we genotyped 213 cases and 197 controls for SNPs previously associated with schizophrenia: rs2111902 (MDAAO-4), rs3918346 (MDAAO-5), rs3741775 (MDAAO-6) and rs3918347 (MDAAO-7) in DAO and rs746187 (M7), rs3916966 (M13), rs2391191 (M15) and rs3916972 (M25) in G72.
|
18165970 |
2008 |
|
rs3741775
|
|
|
0.020 |
GeneticVariation |
BEFREE |
In order to evaluate the potential association of these two genes with schizophrenia in a Taiwanese sample, three single nucleotide polymorphisms (SNPs) for DAAO (rs2111902, rs3918346, rs3741775) and eleven SNPs for G72 (rs3916965, rs3916966, rs3916967, rs2391191, rs3916968, rs947267, rs778294, rs3916970, rs3916971, rs778293, rs3918342) were genotyped by the MALDI-TOF mass spectrometry method in 218 families (864 individuals) containing at least two siblings affected with schizophrenia.
|
16842973 |
2006 |
|
rs2070586
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Interestingly, however, we found gender-specific differences in allele distributions, with SNP rs2070586 appearing to act as a risk allele in female schizophrenia patients, but as a protective allele in males.
|
20483168 |
2010 |